You just read:

BioAxone BioSciences Awarded NINDS SBIR Funding for the Development of Self-Delivering RNAi (sd-rxRNA®) for the Treatment of Spinal Cord Injury

News provided by

RXi Pharmaceuticals Corporation

Sep 15, 2017, 07:05 ET